Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1808-2025Class II

BD Cathena Safety IV Catheter BD Multiguard Technology 18 GA x 1.25 IN, REF: 386865; BD Cathena Safety IV...

Becton Dickinson Infusion Therapy Systems Inc. / initiated 2025-04-21 / Open, Classified / root cause: manufacturing process

Becton Dickinson Infusion Therapy Systems, Inc. began a recall of BD Cathena Safety IV Catheter BD Multiguard Technology 18 GA x 1.25 IN, REF: 386865; BD Cathena Safety IV Catheter 20GX1.00IN STRAIGHT BC, REF: 386803; BD... on . FDA classified it as Class II and gives the reason as "Due to a manufacturing defect IV catheter may have a hole in the septum, which may result in blood leakage from the septum during insertion, which may cause blood exposure or the need for a second IV to be placed -...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1808-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Becton Dickinson Infusion Therapy Systems Inc.
Product
BD Cathena Safety IV Catheter BD Multiguard Technology 18 GA x 1.25 IN, REF: 386865; BD Cathena Safety IV Catheter 20GX1.00IN STRAIGHT BC, REF: 386803; BD Cathena Safety IV Catheter BD Multiguard Technology 20 GA x 1.00 IN, 386862
Product code
FOZ Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days
Reason for recall
Due to a manufacturing defect IV catheter may have a hole in the septum, which may result in blood leakage from the septum during insertion, which may cause blood exposure or the need for a second IV to be placed - which may result in therapy delay.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On 4/21/2025, Removal notices were sent (mail/email/fax/phone) to Medical Directors, Risk Managers, Medical Device Safety Officers, Nurse Managers, and distributors were informed of the following: - Routine clinical practice of PPE should protect the clinician from mucocutaneous blood exposure. - If leakage from the septum occurs during insertion, the PIVC should no longer be used. It is recommended the clinician places a new PIVC. In addition, they were asked to do the following: 1) Destroy all unused product subject to the recall following your institution's process for destruction. 2. For indwelling catheters, no further action is needed. 3. If a defective product was previously used on a patient with no issues, no further actions are needed. 4. Share this recall notification with all users within your facility network of the product to ensure they are also aware of this recall. 5. Complete and return Customer Response Form via email to Email: [email protected] 6. Distributors were asked to identify all customers within their distribution network that purchased any affected product. Then, Provide a copy of the attached customer letter to all customers to advise them of this field action notification. Questions or complaints can be reported to the North American Regional Complaint Center, 1-844-823-5433 Mon Fri 8:00am and 5:00pm CT or Email: [email protected]
Quantity in commerce
262,800
Distribution
Worldwide - US Nationwide distribution in the states of IN, AL, CA, FL, TX, NJ, MO, NC, NY, OH, AZ, MN, MA, WA, OK, KS, MS, LA, MD, GA, TN, NM, PA and the country of CA.
Product codes and lots
REF/UDI-DI/Lot/Expiration: 386865/0100382903868650/4198480/30-Jun-2027, 386803/0100382903868032/4247809/31-Aug-2027, 386862/0100382903868629/4237744/31-Aug-2027

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1808-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1808-2025Class IIOngoingVoluntary: Firm initiated